Explore the frontiers of medical technology in this episode of the Tech Optimist, as Alumni Ventures' Managing Partner Ludwig Pierre Schulze sits down with Michael Mager, CEO and Co-Founder of Precision Neuroscience. They delve into the revolutionary development of brain-computer interfaces that could dramatically change lives for those with neurological conditions. Michael shares insights into Precision Neuroscience's pioneering technology, which includes a minimally invasive method for integrating advanced computing directly with brain activity. This conversation highlights how their work is pushing the boundaries of medical science and opening new possibilities for restoring function and enhancing life quality for people affected by paralysis, stroke, and other serious conditions. 

To Learn More:

• Alumni Ventures (AV)
• AV LinkedIn
• AV Healthtech Fund
• Tech Optimist
• Precision Neuroscience

Speakers:

• Ludwig Pierre Schulze - Guest 
• Michael Mager - Guest 

Chapters:

• (00:00) - Intro

Legal Disclosure:

• https://av-funds.com/tech-optimist-disclosures